Flublok uses an egg-free system, which means that manufacturing it doesn’t require influenza virus or antibiotics.
Protein Sciences expanded Flublok distribution through Cardinal, McKesson this week.
Protein Sciences Corp. last week announced that the Food and Drug Administration approved Flublok influenza vaccine for all adults ages 18 years and older.
Protein Sciences Corp. on Monday announced today that doses of its Flublok influenza vaccine have been released and are now available for shipment.
The Food and Drug Administration on Wednesday approved Protein Sciences' Flublok, the first trivalent influenza vaccine made using an insect virus (baculovirus) expression system and recombinant DNA technology.